Thai H Ho

Thai H Ho

UNVERIFIED PROFILE

Are you Thai H Ho?   Register this Author

Register author
Thai H Ho

Thai H Ho

Publications by authors named "Thai H Ho"

Are you Thai H Ho?   Register this Author

52Publications

1605Reads

43Profile Views

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.

Cancer Med 2019 Jul 30. Epub 2019 Jul 30.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2402DOI Listing
July 2019

Behavior of blood plasma glycan features in bladder cancer.

PLoS One 2018 24;13(7):e0201208. Epub 2018 Jul 24.

School of Molecular Sciences, Arizona State University, Tempe, AZ, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201208PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057681PMC
January 2019

Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model.

Clin Exp Hypertens 2018 27;40(6):524-533. Epub 2017 Nov 27.

a Department of Internal Medicine (Division of Cardiology) , The Ohio State University College of Medicine , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10641963.2017.1403623DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203326PMC
October 2018

The Impact of Pazopanib on the Cardiovascular System.

J Cardiovasc Pharmacol Ther 2018 09 29;23(5):387-398. Epub 2018 Apr 29.

1 Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1074248418769612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257996PMC
September 2018

Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia.

Elife 2017 12 19;6. Epub 2017 Dec 19.

Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7554/eLife.31132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739538PMC
December 2017

Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.

JCO Precis Oncol 2017 1;2017. Epub 2017 Aug 1.

David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos, Ezequiel J. Tolosa, Ryan M. Carr, Stephanie L. Safgren, Elisa Enriquez Hesles, Luciana L. Almada, Paola A. Romecin-Duran, Eriko Iguchi, Aryan Ala'Aldeen, Jean-Pierre A. Kocher, Gavin R. Oliver, Naresh Prodduturi, David W. Mead, Asif Hossain, Norine E. Huneke, Colleen M. Tagtow, Sikander Ailawadhi, Stephen M. Ansell, Michaela S. Banck, Asher A. Chanan-Khan, Ronald S. Go, Thorvardur R. Halfdanarson, Richard W. Joseph, Prashant Kapoor, Aaron S. Mansfield, Amulya A. Nageswara Rao, Grzegorz S. Nowakowski, Animesh Pardanani, Sameer A. Parikh, John C. Cheville, Andrew L. Feldman, Ramesh K. Ramanathan, Steven I. Robinson, Heidi D. Finnes, Jennifer B. McCormick, Robert R. McWilliams, Aminah Jatoi, Mrinal M. Patnaik, Eric D. Wieben, Tammy M. McAllister, Kandelaria M. Rumilla, Sarah E. Kerr, Konstantinos N. Lazaridis, Gianrico Farrugia, Karl J. Clark, Eric W. Klee, and Martin E. Fernandez-Zapico, Mayo Clinic, Rochester; Ernesto Resnik, Bio-Techne, Minneapolis, MN; Sikander Ailawadhi, Asher A. Chanan-Khan, and Richard W. Joseph, Mayo Clinic, Jacksonville, FL; Jan B. Egan, Alan H. Bryce, Estrella M. Carballido, KellyK. Curtis, Chelsea D. Gawryletz, Thai H. Ho,Nathalie Meurice, Ramesh K. Ramanathan, Raoul Tibes, Alvin C. Silva, A. Keith Stewart, and Mitesh J. Borad, Mayo Clinic, Phoenix, AZ; and Eileen J. Kennedy, University of Georgia, Athens, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369924PMC
August 2017

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.

Clin Genitourin Cancer 2017 04 8;15(2):196-202.e1. Epub 2016 Sep 8.

Department of Urology, Mayo Clinic Arizona, Phoenix, AZ. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.08.026DOI Listing
April 2017

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.

Eur Urol Focus 2016 Dec 2;2(6):608-615. Epub 2016 Apr 2.

Division of Hematology and Oncology and Cancer Center and Breast Clinic, Mayo Clinic, Jacksonville, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2016.03.008DOI Listing
December 2016

Dual Chromatin and Cytoskeletal Remodeling by SETD2.

Cell 2016 Aug;166(4):950-962

Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2016.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101839PMC
August 2016

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis.

J Transl Med 2016 07 2;14(1):198. Epub 2016 Jul 2.

Division of Hematology and Medical Oncology, Mayo Clinic, 13400 East Shea Blvd, Scottsdale, AZ, 85259, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-0953-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930561PMC
July 2016

The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.

Science 2016 Jun 26;352(6291):1344-8. Epub 2016 May 26.

Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. Epigenomics Program, Center of Individualized Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aae0065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460624PMC
June 2016

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.

Eur Urol Focus 2016 Jun 9;2(2):204-209. Epub 2015 Dec 9.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2015.11.007DOI Listing
June 2016

Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic renal cell carcinoma by tyrosine kinase inhibitors.

J Clin Ultrasound 2016 May 15;44(4):221-30. Epub 2016 Feb 15.

Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Arizona, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.22333DOI Listing
May 2016

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.

Cell Rep 2016 Mar 3;14(10):2476-89. Epub 2016 Mar 3.

Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.02.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794376PMC
March 2016

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.

J Urol 2016 Jan 20;195(1):180-7. Epub 2015 Aug 20.

Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal Medicine and Department of Developmental Biology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, Minnesota; Division of Medical Oncology, Mayo Clinic Arizona, Phoenix, Arizona. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.07.113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221690PMC
January 2016

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

Authors:
W Marston Linehan Paul T Spellman Christopher J Ricketts Chad J Creighton Suzanne S Fei Caleb Davis David A Wheeler Bradley A Murray Laura Schmidt Cathy D Vocke Myron Peto Abu Amar M Al Mamun Eve Shinbrot Anurag Sethi Samira Brooks W Kimryn Rathmell Angela N Brooks Katherine A Hoadley A Gordon Robertson Denise Brooks Reanne Bowlby Sara Sadeghi Hui Shen Daniel J Weisenberger Moiz Bootwalla Stephen B Baylin Peter W Laird Andrew D Cherniack Gordon Saksena Scott Haake Jun Li Han Liang Yiling Lu Gordon B Mills Rehan Akbani Mark D M Leiserson Benjamin J Raphael Pavana Anur Donald Bottaro Laurence Albiges Nandita Barnabas Toni K Choueiri Bogdan Czerniak Andrew K Godwin A Ari Hakimi Thai H Ho James Hsieh Michael Ittmann William Y Kim Bhavani Krishnan Maria J Merino Kenna R Mills Shaw Victor E Reuter Ed Reznik Carl S Shelley Brian Shuch Sabina Signoretti Ramaprasad Srinivasan Pheroze Tamboli George Thomas Satish Tickoo Kenneth Burnett Daniel Crain Johanna Gardner Kevin Lau David Mallery Scott Morris Joseph D Paulauskis Robert J Penny Candace Shelton W Troy Shelton Mark Sherman Eric Thompson Peggy Yena Melissa T Avedon Jay Bowen Julie M Gastier-Foster Mark Gerken Kristen M Leraas Tara M Lichtenberg Nilsa C Ramirez Tracie Santos Lisa Wise Erik Zmuda John A Demchok Ina Felau Carolyn M Hutter Margi Sheth Heidi J Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean C Zenklusen Jiashan Zhang Brenda Ayala Julien Baboud Sudha Chudamani Jia Liu Laxmi Lolla Rashi Naresh Todd Pihl Qiang Sun Yunhu Wan Ye Wu Adrian Ally Miruna Balasundaram Saianand Balu Rameen Beroukhim Tom Bodenheimer Christian Buhay Yaron S N Butterfield Rebecca Carlsen Scott L Carter Hsu Chao Eric Chuah Amanda Clarke Kyle R Covington Mahmoud Dahdouli Ninad Dewal Noreen Dhalla Harsha V Doddapaneni Jennifer A Drummond Stacey B Gabriel Richard A Gibbs Ranabir Guin Walker Hale Alicia Hawes D Neil Hayes Robert A Holt Alan P Hoyle Stuart R Jefferys Steven J M Jones Corbin D Jones Divya Kalra Christie Kovar Lora Lewis Jie Li Yussanne Ma Marco A Marra Michael Mayo Shaowu Meng Matthew Meyerson Piotr A Mieczkowski Richard A Moore Donna Morton Lisle E Mose Andrew J Mungall Donna Muzny Joel S Parker Charles M Perou Jeffrey Roach Jacqueline E Schein Steven E Schumacher Yan Shi Janae V Simons Payal Sipahimalani Tara Skelly Matthew G Soloway Carrie Sougnez Angela Tam Donghui Tan Nina Thiessen Umadevi Veluvolu Min Wang Matthew D Wilkerson Tina Wong Junyuan Wu Liu Xi Jane Zhou Jason Bedford Fengju Chen Yao Fu Mark Gerstein David Haussler Katayoon Kasaian Phillip Lai Shiyun Ling Amie Radenbaugh David Van Den Berg John N Weinstein Jingchun Zhu Monique Albert Iakovina Alexopoulou Jeremiah J Andersen J Todd Auman John Bartlett Sheldon Bastacky Julie Bergsten Michael L Blute Lori Boice Roni J Bollag Jeff Boyd Erik Castle Ying-Bei Chen John C Cheville Erin Curley Benjamin Davies April DeVolk Rajiv Dhir Laura Dike John Eckman Jay Engel Jodi Harr Ronald Hrebinko Mei Huang Lori Huelsenbeck-Dill Mary Iacocca Bruce Jacobs Michael Lobis Jodi K Maranchie Scott McMeekin Jerome Myers Joel Nelson Jeremy Parfitt Anil Parwani Nicholas Petrelli Brenda Rabeno Somak Roy Andrew L Salner Joel Slaton Melissa Stanton R Houston Thompson Leigh Thorne Kelinda Tucker Paul M Weinberger Cynthia Winemiller Leigh Anne Zach Rosemary Zuna

Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma.

Oncotarget 2016 Jan;7(2):1927-46

Department of Molecular Pharmacology and Experimental Therapeutics and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811507PMC
January 2016

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma.

BMC Cancer 2015 Apr 18;15:304. Epub 2015 Apr 18.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1302-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406182PMC
April 2015

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.

Urol Oncol 2015 Feb 28;33(2):68.e17-23. Epub 2014 Aug 28.

Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2014.07.019DOI Listing
February 2015

Genetic kidney cancer syndromes.

J Natl Compr Canc Netw 2014 Sep;12(9):1347-55

From the Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona, and Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
September 2014

Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer.

Can J Urol 2014 Jun;21(3):7259-65

Mayo Clinic Hospital, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
June 2014

Axitinib in the treatment of metastatic renal cell carcinoma.

Future Oncol 2011 Nov;7(11):1247-53

Department of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.11.107DOI Listing
November 2011

Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.

J Cell Sci 2005 Jul 16;118(Pt 13):2923-33. Epub 2005 Jun 16.

Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://jcs.biologists.org/cgi/doi/10.1242/jcs.02404
Publisher Site
http://dx.doi.org/10.1242/jcs.02404DOI Listing
July 2005

Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.

Hum Mol Genet 2005 Jun 20;14(11):1539-47. Epub 2005 Apr 20.

Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://hmg.oxfordjournals.org/content/14/11/1539.full.pdf
Web Search
http://www.hmg.oupjournals.org/cgi/doi/10.1093/hmg/ddi162
Publisher Site
http://dx.doi.org/10.1093/hmg/ddi162DOI Listing
June 2005

Muscleblind proteins regulate alternative splicing.

EMBO J 2004 Aug 15;23(15):3103-12. Epub 2004 Jul 15.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.emboj.7600300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC514918PMC
August 2004

Simple mimetics of a nuclear localization signal (NLS).

Org Lett 2003 Jul;5(14):2437-40

University of Illinois at Chicago, Department of Chemistry (M/C 111), 845 West Taylor Street, Room 4500, Chicago, Illinois 60607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ol034640tDOI Listing
July 2003

The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion.

J Cell Biol 2002 Jun 10;157(6):963-74. Epub 2002 Jun 10.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.jcb.org/lookup/doi/10.1083/jcb.200111077
Publisher Site
http://dx.doi.org/10.1083/jcb.200111077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174045PMC
June 2002